Antibiotic treatment adequacy and death among patients with Pseudomonas aeruginosa airway infection.
Josefin EklöfKirstine Møller GlieseTruls Sylvan IngebrigtsenUffe BødtgerJens-Ulrik Stæhr JensenPublished in: PloS one (2019)
Adequate antipseudomonal therapy was only provided in a minority of patients with pulmonary P. aeruginosa. Adequate therapy did not independently predict a favourable outcome. New research initiatives are needed to improve the prognosis of this vulnerable group of patients.
Keyphrases
- pseudomonas aeruginosa
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- cystic fibrosis
- pulmonary hypertension
- peritoneal dialysis
- prognostic factors
- quality improvement
- patient reported outcomes
- staphylococcus aureus
- mesenchymal stem cells
- acinetobacter baumannii
- combination therapy